Academic Articles & Research Papers

Uncovering disability progression in people with multiple sclerosis: a practical guide.

Van Wijmeersch B, Oreja-Guevara C, Magyari M, Airas L et al. • Journal of neurology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1007/s00415-026-14212-2 PMC: PMC13731484

View Article » Original Source ↗

Attitudes towards vaccination in multiple sclerosis: insights from patients, neurologists, and general practitioners within a qualitative study.

Suslow A, Lauer R, Grüter T, Hellwig K et al. • BMC neurology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12883-026-05590-1 PMC: PMC13733131

View Article » Original Source ↗

Improving work outcomes in people with multiple sclerosis: A scoping review of non-pharmacological interventions.

Saddal SR, De Dios Perez B, Machado A, Friberg E et al. • Clinical rehabilitation (2026)

PMC PMC Public Access (View-Only) DOI: 10.1177/02692155261454943 PMC: PMC13736301

View Article » Original Source ↗

Longitudinal analysis of the effects of cladribine tablets on B and T cell memory recall responses to vaccine antigens in people with multiple sclerosis.

Csurhes PA, McCombe PA, Greer JM • Frontiers in immunology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fimmu.2026.1881334 PMC: PMC13735715

View Article » Original Source ↗

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Yoo PY, Zarandi A, Stephens S, To T et al. • Multiple sclerosis (Houndmills, Basingstoke, England) (2026)

PMC PMC Public Access (View-Only) DOI: 10.1177/13524585261453239 PMC: PMC13538933

View Article » Original Source ↗

The HLA paradox across populations in multiple sclerosis progression: a systematic review.

Maghbooli Z, Nasir E, Mahdavinasab F, Sahraian MA et al. • BMC neurology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12883-026-05100-3 PMC: PMC13548618

View Article » Original Source ↗

Delivering high-quality multiple sclerosis care in Germany: challenges and regional models.

Pawlitzki M, Huntemann N, Masanneck L, Werner NM et al. • Neurological research and practice (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s42466-026-00531-2 PMC: PMC13551735

View Article » Original Source ↗

Relapse prediction and individualized treatment-effect modeling in relapsing multiple sclerosis: a systematic review.

Budil M, Rožánek M, Petrová P • Frontiers in public health (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fpubh.2026.1940704 PMC: PMC13587037

View Article » Original Source ↗

Downregulation of IFNG-AS1 and UCHL1-AS1 in Peripheral Blood Cells of Multiple Sclerosis Patients: IFNG-AS1 as a Candidate Diagnostic Biomarker.

Rajabi A, Gross JD, Samadi A • International journal of genomics (2026)

PMC PMC Public Access (View-Only) DOI: 10.1155/ijog/7231094 PMC: PMC13589247

View Article » Original Source ↗

CAR-T Cell Therapy and Gut Microbiota Modulation in Multiple Sclerosis: Emerging Therapeutic Strategies and Current Limitations.

Chasov V, Mukhametshin S, Valiullina A, Skibo Y et al. • Current issues in molecular biology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3390/cimb48090958 PMC: PMC13605810

View Article » Original Source ↗

Racial and ethnic disparities in disease-modifying therapy use among adults with multiple sclerosis: a real-world analysis of the All of Us Research Program.

Fontánez-Ramos V, Barreto-Nieves J, Carrasquillo-Sanabria GA, García-Báez JF et al. • Frontiers in neurology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fneur.2026.1916567 PMC: PMC13616653

View Article » Original Source ↗

The hidden toll: Atrophy of key central nervous system relays in African American women with multiple sclerosis.

Nathoo N, Neyal N, Son J, Schwarz CG et al. • Journal of neuroimmunology (2025)

PMC PMC Public Access (View-Only) DOI: 10.1016/j.jneuroim.2025.578776 PMC: PMC12705190

View Article » Original Source ↗

Prevalence and Odds of Bipolar Disorder in Patients with Multiple Sclerosis (MS): a Systematic Review and Meta-Analysis.

Pourshams M, Rashidpour P, Malekpour N, Rastkar M et al. • Maedica (2026)

PMC PMC Public Access (View-Only) DOI: 10.26574/maedica.2026.21.3.705 PMC: PMC13650648

View Article » Original Source ↗

Toward regionally equitable precision medicine: microbiota‑associated mechanisms and emerging personalized strategies in multiple sclerosis.

Alshinnawy AS, Rashwan EA, Swelam MS, Mohamed MR et al. • Journal of translational medicine (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12967-026-08830-7 PMC: PMC13653396

View Article » Original Source ↗

Comparator Event Rates, Baseline Activity, and Operational Selection Pressure in Relapsing Multiple Sclerosis Trials: A Meta-Epidemiological Analysis.

Pfeuffer S, Masanneck L, Pawlitzki M, Hartung HP • European journal of neurology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1111/ene.70781 PMC: PMC13653506

View Article » Original Source ↗

The multiple sclerosis exposome: environmental determinants, immunological convergence, and the Gulf Region as a natural test case.

Shosha E, Qadi N • Frontiers in immunology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fimmu.2026.1941832 PMC: PMC13678491

View Article » Original Source ↗

Incident Comorbid Diabetes and Outcomes in Multiple Sclerosis: An English Population-Based Cohort Study.

Lau Y, Zabihi S, Hartmann M, Mathlin G et al. • Annals of clinical and translational neurology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1002/acn3.70548 PMC: PMC13682410

View Article » Original Source ↗

Social Determinants of Health in Multiple Sclerosis in Jackson, Mississippi: Focus Groups.

Mateen FJ, Awori V, Hill JB, Willis MA • International journal of MS care (2026)

PMC PMC Public Access (View-Only) DOI: 10.7224/1537-2073.2025-044 PMC: PMC13694028

View Article » Original Source ↗

From Global Evidence to Saudi Practice: A Structured Evidence Map of the Diagnosis, Molecular Targets, and Therapeutic Strategies of Multiple Sclerosis in the Kingdom of Saudi Arabia.

Mir R, Algehainy NA, Jalal MM, Altayar MA et al. • Diseases (Basel, Switzerland) (2026)

PMC PMC Public Access (View-Only) DOI: 10.3390/diseases14100382 PMC: PMC13703117

View Article » Original Source ↗

Non-PML neuroinvasive infections reported with multiple sclerosis disease-modifying therapies: a mechanism-based pharmacovigilance study, 2004-2025.

Ke L, Jiang S, Duan J, Xing W • Frontiers in immunology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fimmu.2026.1959164 PMC: PMC13710094

View Article » Original Source ↗